Continued improvement and normalization of myocardial T2*in patients with beta-thalassemia major treated with deferasirox (Exjade (R)) for up to 3 years

Authors

• D. Pennell
• J.B. Porter
• M.D. Cappellini
• L.L. Chan
• A. El-Beshlawy
• Y. Aydinok
• H. Ibrahim
• Chi-Kong Li
• V. Viprakasit
• M.S. Elalfy
• A. Kattamis
• G. Smith
• D. Habr
• G. Domokos
• B. Roubert
• A. Taher

Document Type

Article

Publication Date

1-1-2010

Publication Title

Blood

Recommended Citation

Pennell, D.; Porter, J.B.; Cappellini, M.D.; Chan, L.L.; El-Beshlawy, A.; Aydinok, Y.; Ibrahim, H.; Li, Chi-Kong; Viprakasit, V.; Elalfy, M.S.; Kattamis, A.; Smith, G.; Habr, D.; Domokos, G.; Roubert, B.; and Taher, A., "Continued improvement and normalization of myocardial T2*in patients with beta-thalassemia major treated with deferasirox (Exjade (R)) for up to 3 years" (2010). Research Publications (2006 to 2010). 3279.
https://knova.um.edu.my/research_publications_2006_2010/3279

Volume

116

Issue

21

Publisher

Amer Soc Hematology

Publisher Location

1900 M STREET. NW SUITE 200, WASHINGTON, DC 20036 USA

Additional Information

52nd Annual Meeting of the American-Society-of-Hematology (ASH), Orlando, FL, DEC 04-07, 2010